Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Patients and data tracking

NHS mass overspend on insulin

A joint investigation from the BMJ and Channel 4 News has suggested the NHS has wasted £250m on insulin treatments over the past five years

NICE rejects Avastin for breast cancer

The National Institute for Health and Clinical Excellence has recommended against the use of Roche's Avastin for the treatment of metastatic breast cancer

NICE recommends aripiprazole

NICE's FAD recommends the use of Bristol-Myers Squibb's atypical anti-psychotic drug Abilify (aripiprazole) as an option for the treatment of adolescent schizophrenia

Campaign to reduce NHS wastage launched

A campaign aimed at reducing an estimated £50m wasted on medicines has been launched by four Primary Care Trusts in Greater London

GP Consortia Network planned

The RCGP and the NHS Confederation are working to explore setting up a network to support and represent GP commissioning consortia in England

UK’s RCGP names new CEO

The Royal College of General Practitioners has appointed Neil Hunt as its new CEO, while new chair, Dr Clare Gerada, outlines the eight key priorities for her tenure

Key cancer area improvement in England

A new report has announced improvements for key areas of cancer in England since the publication of the Cancer Reform Strategy

- PMLiVE

QiC Programme now online

The Quality in Care Programme – a new initiative to celebrate good healthcare practice in the UK – has launched a website and blog

DH health analysis provider to be sold

The UK's Department of Health is to sell its health information provider Dr Foster Intelligence, in which it holds a minority stake

NTAC campaign delivers on QIPP

An NHS campaign to encourage UK specialists to adopt latest medical technology has proven a success, engaging more than 20,000 doctors

Decline in NICE drug approvals

An analysis of appraisals from the UK's National Institute for Health and Clinical Excellence has found access to drugs grew more restrictive between 2007 and 2009

NICE recommends against azacitidine

The UK’s NICE has recommended against the use of azacitidine for certain haematological conditions in draft guidance

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links